Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123155653 | 12315565 | 3 | F | 20160712 | 20160428 | 20160726 | EXP | CA-HQ SPECIALTY-CA-2016INT000233 | INTERCHEM | 0.00 | F | Y | 0.00000 | 20160726 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123155653 | 12315565 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | U | 201749 | ||||||||||
| 123155653 | 12315565 | 2 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 3 | SS | ENBREL | ETANERCEPT | 1 | UNK | Y | 0 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||
| 123155653 | 12315565 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG, 2 IN 1 D) | Y | 0 | 5 | MG | TABLET | ||||||
| 123155653 | 12315565 | 5 | C | ARAVA | LEFLUNOMIDE | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 6 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 7 | C | HUMIRA | ADALIMUMAB | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 8 | C | ORENCIA | ABATACEPT | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 9 | C | REMICADE | INFLIXIMAB | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 10 | C | RITUXAN | RITUXIMAB | 1 | UNK | U | 0 | ||||||||||
| 123155653 | 12315565 | 11 | C | ACTEMRA | TOCILIZUMAB | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123155653 | 12315565 | 1 | Rheumatoid arthritis |
| 123155653 | 12315565 | 2 | Pain |
| 123155653 | 12315565 | 3 | Rheumatoid arthritis |
| 123155653 | 12315565 | 4 | Rheumatoid arthritis |
| 123155653 | 12315565 | 5 | Rheumatoid arthritis |
| 123155653 | 12315565 | 6 | Rheumatoid arthritis |
| 123155653 | 12315565 | 7 | Rheumatoid arthritis |
| 123155653 | 12315565 | 8 | Rheumatoid arthritis |
| 123155653 | 12315565 | 9 | Rheumatoid arthritis |
| 123155653 | 12315565 | 10 | Rheumatoid arthritis |
| 123155653 | 12315565 | 11 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123155653 | 12315565 | OT |
| 123155653 | 12315565 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123155653 | 12315565 | Arthropathy | |
| 123155653 | 12315565 | Drug ineffective | |
| 123155653 | 12315565 | Dyspnoea | |
| 123155653 | 12315565 | Hypertension | |
| 123155653 | 12315565 | Localised infection | |
| 123155653 | 12315565 | Musculoskeletal stiffness | |
| 123155653 | 12315565 | Pain | |
| 123155653 | 12315565 | Peripheral swelling | |
| 123155653 | 12315565 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123155653 | 12315565 | 4 | 20150814 | 2016 | 0 |